| |
| |
|
| Insider
Information: |
Lanchbury Jerry S |
| Relationship: |
Chief Scientific Officer |
| City: |
Salt Lake City |
| State: |
UT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
264,324 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,132,317 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
264,324 |
|
|
| Total
Value |
$6,132,317 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myriad Genetics Inc |
MYGN |
Chief Scientific Officer |
2021-10-09 |
264,324 |
2006-11-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2007-05-01 |
4 |
AS |
$37.00 |
$323,750 |
D/D |
(8,750) |
0 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-09-25 |
4 |
D |
$33.31 |
$324,673 |
D/D |
(9,747) |
278,768 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2008-09-03 |
4 |
OE |
$16.64 |
$332,800 |
D/D |
20,000 |
26,500 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-10-09 |
4 |
D |
$30.88 |
$333,844 |
D/D |
(10,811) |
264,324 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2014-07-14 |
4 |
OE |
$18.06 |
$361,200 |
D/D |
20,000 |
34,551 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-05-04 |
4 |
OE |
$19.47 |
$376,939 |
D/D |
19,360 |
285,282 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2017-09-30 |
4 |
D |
$36.18 |
$409,847 |
D/D |
(11,328) |
138,809 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2014-02-18 |
4 |
OE |
$12.17 |
$427,217 |
D/D |
34,192 |
41,743 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2007-08-09 |
4 |
AS |
$47.00 |
$470,006 |
D/D |
(10,000) |
0 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2015-10-26 |
4 |
AS |
$41.80 |
$480,324 |
D/D |
(11,491) |
70,737 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2018-09-30 |
4 |
D |
$46.00 |
$492,246 |
D/D |
(10,701) |
166,049 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2015-10-27 |
4 |
AS |
$41.80 |
$515,645 |
D/D |
(12,336) |
70,737 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2007-09-27 |
4 |
AS |
$52.00 |
$521,876 |
D/D |
(10,036) |
0 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-11-19 |
4 |
OE |
$8.63 |
$522,465 |
D/D |
49,004 |
37,735 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-02-01 |
4 |
AS |
$24.05 |
$524,338 |
D/D |
(21,804) |
22,735 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-12-03 |
4 |
AS |
$27.18 |
$543,680 |
D/D |
(20,000) |
17,735 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-05-04 |
4 |
AS |
$31.97 |
$618,949 |
D/D |
(19,360) |
265,922 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2007-08-07 |
4 |
AS |
$42.00 |
$630,918 |
D/D |
(15,000) |
0 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2012-03-15 |
4 |
AS |
$25.00 |
$663,503 |
D/D |
(26,536) |
22,735 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2008-12-18 |
4 |
S |
$67.00 |
$670,000 |
D/D |
(10,000) |
13,214 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2009-12-23 |
4 |
AS |
$26.01 |
$687,419 |
D/D |
(26,428) |
20,000 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-08-05 |
4 |
OE |
$27.07 |
$764,051 |
D/D |
28,225 |
260,775 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-04-27 |
4 |
OE |
$19.47 |
$778,800 |
D/D |
40,000 |
305,922 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Executive V.P. - Research |
• – – |
2007-10-05 |
4 |
AS |
$57.00 |
$792,897 |
D/D |
(10,000) |
0 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2014-07-14 |
4 |
AS |
$39.85 |
$797,082 |
D/D |
(20,000) |
14,551 |
0 |
- |
|
140 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
